Rezigene

Broad-spectrum therapies for neurodegeneration designed to combat proteotoxicity in FTD, ALS, and more by restoring healthy cellular protein quality control

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Baltimore, MD, USA
  • Currency USD
  • Founded May 2023
  • Employees 3
  • Incorporation Type LLC
  • Website Stealth

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free